PATENT CLAIM ANALYSIS

Application Number: 15949993
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2019-01
Patent Classification: ["424", "085200"]

Abstract:
The present disclosure relates to a composition for treating or preventing an inflammatory disease, and more particularly, to a composition for treating or preventing a herpes simplex virus infection containing interleukin-15 and interleukin-15 receptor alpha-Fc.

Claim (Index 6):
The method of  claim 1 , wherein the composition is administered intravenously, subcutaneously, or intramuscularly.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 91.0
- Lexical Diversity: 1.40741
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13769179', '15083998', '13391615', '13854903', '15213991']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7398732981353736
- 35 USC 102 Novelty (BERT): 0.5082108884682441
- Combined Prediction Score: 0.7167070571686607
- Mean Citation Score: 250.808238
- Max Citation Score: 255.71124
- Similarity Product: 169.91685679465772

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test